Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance
Authors:
- 1 July 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 489 (1-2) , 318-330
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Fund Project of China (81402868)
- Foundation for OutstandingYoung Scientist in Shandong Province (BS2014YY007)
- Natural Science Foundation Program of Shandong Province (2012ZRE27239)
This publication has 43 references indexed in Scilit:
- A novel liposome-encapsulated hemoglobin/silica nanoparticle as an oxygen carrierInternational Journal of Pharmaceutics, 2012
- Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid BilayersACS Nano, 2012
- Mesoporous Silica Nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water Soluble DrugsMolecular Pharmaceutics, 2012
- Expert opinion: Responsive polymer nanoparticles in cancer therapyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2012
- Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistanceBiomaterials, 2010
- Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticlesInternational Journal of Pharmaceutics, 2010
- Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systemsChemical Communications, 2007
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal of Cancer, 1996
- Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy AdministrationJNCI: Journal of the National Cancer Institute, 1991